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Genetic Diversity of Staphylococcus aureus in Lebanon 
Houda Haitham Harastani 
Abstract 
Staphylococcus aureus, one of the most significant human pathogens, causes 
different infections ranging in severity from mild superficial skin infections to life 
threatening bacteremia and endocarditis. The occurrence and dissemination of 
methicillin-resistant variants (MRSAs) in clinical settings has raised the concern for the 
constant increase of nosocomial infections all over the world. Additionally, the 
appearance of MRSA among the community (community acquired [CA-MRSA]) and its 
risk of being introduced into hospitals is a matter of great concern. Effective 
epidemiological studies based on typing are indispensible for confirming the genetic 
relatedness of closely related isolates belonging to the same clonal lineages as well as 
for screening and controlling the occurrence and spread of epidemic clones in the region. 
This study aimed at the molecular characterization of S. aureus in Lebanon. 132 S. 
aureus isolates, 39 MRSA and 93 Methicillin-susceptible (MSSA), were collected from 
the American University of Beirut Medical Center (AUB-MC) and were characterized 
using different typing methods including S. aureus protein A (spa) typing, 
staphylococcal chromosomal cassette (SCCmec) typing of MRSA, multilocus sequence 
typing (MLST) and Pulsed-Field Gel Electrophoresis (PFGE). The detection of Panton-
Valentine Leukocidin (PVL) and the distribution of SCCmec types I-VIII were 
performed by multiplex PCR assays. PVL were detected in 54% of MRSA and 12% of 
MSSA. Seventy one different spa types were identified and clustered into 40 groups 
with the most common spa type being t044 (13%) among MRSA and t021 (8%) among 
MSSA. SCCmec typing showed the prevalence of types IV (d, e, f, g, and h) (49%) 
followed by IVa (31%), V (13%), IVc (5%) and III (3%). Twenty five allelic profiles or 
STs were identified by MLST with the major STs being ST80 (11%) and ST30 (8%). 
PFGE revealed 32 groups by applying 80% as a cutoff similarity. Clustering mec typing 
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with MLST revealed that ST80-MRSA-IV and ST30-MSSA were the predominant 
clones in Lebanon. The present study showed the great diversity between MRSA and 
MSSA isolates in Lebanon compared to previous conducted studies. Systematic 
surveillance is required for isolates associated with both hospital- and community-
acquired infections to limit and control the spread of S. aureus. Future studies with 
larger number of samples from different countries are essential in order to better assess 
and characterize MRSA and MSSA in the region.  Determining the prevailing genetic 
populations in Lebanon along with their prevalence in causing diseases will help in 
developing measures to control the spread of these potentially serious infections. 
 
Keywords: Staphylococcus aureus, MRSA, MSSA, MLST, spa typing, PFGE, SCCmec 
typing. 
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CHAPTER ONE 
INTRODUCTION 
 
Staphylococcus aureus, a highly adaptive and versatile gram-positive bacterium, 
is considered one of the most commonly isolated human pathogens (McCarthy and 
Lindsay 2010; David and Daum 2010). It colonizes asymptomatically the nasal mucosa 
of around 30% of humans and is responsible for a variety of diseases ranging in severity 
from mild superficial skin infections to life threatening deep-seated infections 
(Yamamoto et al. 2010). It is an important pathogen that has gained interest in the 
healthcare as well as in community settings (Chung et al. 2011). Pathogenesis of S. 
aureus is attributable to a variety of expressed cell-surface as well as secreted virulence 
factors which include: exfoliative toxins, enterotoxins, exotoxins, protein A, catalase and 
others (Xie et al. 2011). Implication of biofilms during infection constitutes an 
additional virulence factor that helps the bacterium persist harsh environments within the 
host and escape the immune system (Dhanawade et al. 2010).  
Epidemiology of S. aureus has been greatly influenced by the prevalence and fast 
expansion of drug-resistant strains which has complicated traditional treatment regimens 
(Xie et al. 2011; Shittu et al. 2011). Soon after the introduction of methicillin for the 
treatment of penicillin-resistant strains, the first methicillin-resistant S. aureus (MRSA) 
strain was isolated (Blanc et al. 2007). These strains conferred resistance not only to 
methicillin but also to antibiotics within the β-lactam family and antibiotics from other 
families as well (Blanc et al. 2007). Since then, MRSA strains became increasingly 
endemic and were prototypes of nosocomial infections and thus collectively known as 
hospital-acquired MRSAs (HA-MRSAs) (Yamamoto et al. 2010; Blanc et al. 2007). 
Later, MRSA strains have shown a capacity for causing outbreaks in the community 
especially in the young and previously un-hospitalized patients suggesting a major 
epidemiological change (Beaume et al. 2010). CA-MRSA became then endemic 
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pathogens with specific clones confined to certain geographical areas (Chambers and 
DeLeo 2009). The increase use of vancomycin as a treatment of choice for the ever 
growing burden of MRSA infections has led to emergence of vancomycin-intermediate 
S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) strains which has limited 
the clinical reliance on vancomycin against invasive MRSA infections (Chambers & 
DeLeo 2009; David & Daum 2010). 
Confronted with these epidemiological changes, knowledge about 
epidemiologically prevalent circulating MRSA clones can help in developing effective 
strategies that aid in controlling spread, optimizing treatment and determining mode of 
pathogenicity (Beaume et al. 2010; Dauwalder et al. 2008). Monitoring the evolutionary 
process of prevalent MRSA clones through current genotyping techniques is a crucial 
step to reveal genetic clonality and relatedness among isolates. Among the most valuable 
typing techniques currently available for understanding pathogen evolution are: spa 
typing, SCCmec typing, MLST and PFGE.  
 In this study, a collection of 132 S. aureus isolates from the AUB-MC collected 
between May-October 2011 were genotyped by PFGE, MLST, spa and SCCmec. 
Objectives of this study were to (i) investigate clonal structure of MSSA and MRSA 
strains collected from AUB-MC, which include a component of expatriate population 
from different countries that help in providing consequent opportunity for dissemination 
of international clones, (ii) explore the relationship between current and previously 
characterized clones in Lebanon as well as those prevalent in the region, (iii) identify the 
risk factors for MRSA carriage among the Lebanese population and (iv) determine the 
antibiotic susceptibility profiles of MSSA and MRSA isolates.  
(Part of this work will be presented at the 112
th
 American society for microbiology general 
meeting held in San Francisco, CA, June 2012).  
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 Overview of Staphylococcus aureus 
 Staphylococcus aureus, a Gram-positive ubiquitous bacterium, is considered the 
causative agent of a broad spectrum of diseases ranging in severity from mild localized 
skin infections to life threatening diseases (Beaume et al. 2010). S. aureus is a normal 
flora that colonizes asymptomatically the nasal passages in approximately 30% of 
normal people (Beaume et al. 2010; Lamers et al. 2011). 
S. aureus is a spherical, non-motile and non-spore forming bacterium (Tolan et 
al. 2010) that occur microscopically as grape-like clusters while forming large golden to 
yellow colonies when cultivated on rich media (Todar 2011). Taxonomically, genus S. 
aureus belongs to the Staphylococcaceae family that also includes three less 
encountered genera: Gamella, Macrococcus and Salinicoccus. The bacterium is a 
facultative anaerobe and has the ability to regulate its metabolism to withstand drastic 
changes in environmental conditions (Beaume et al. 2010; Todar 2011). S. aureus can 
tolerate high salt concentrations up to 15% NaCl and grow at a temperature that ranges 
from 15˚C to 45˚C. It is distinguished by its ability to produce catalase, an enzyme that 
hydrolyzes hydrogen peroxide into water and oxygen gas, and being oxidase negative 
(Todar 2011).  
 S. aureus establishes and causes disease through the production of surface-
associated as well as secreted virulence factors (Fey et al. 2003). The ability of S. aureus 
to form biofilms is an additional virulence factor that helps it to escape antimicrobial 
chemotherapies and to resist host responses (Croes et al. 2009).  
 Treatment of S. aureus in the era of resistance against multi-antimicrobial drugs 
is sometimes associated with failure and increase of disease severity (Graveland et al. 
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2010). Mechanism of resistance is mainly associated with horizontal gene transfer and 
mutations (Chambers and DeLeo 2009). Despite being originally restricted to be a 
hospital-associated pathogen, MRSA has gained an increased dissemination among 
community settings as well, suggesting an epidemiological change (Tavares et al. 2010; 
Lamaro-Cardoso et al. 2009).       
2.2 Occurrence 
 Epidemiology of S. aureus infections has been influenced greatly by the rapid 
emergence of antibiotic resistance (Chambers and DeLeo 2009). Mortality rates due to 
S. aureus infections prior to the introduction of penicillin for medical use in the 1940s 
were approximated to be around 80% (Skinner and Keefer 1941). In 1942, two years 
after the use of penicillin, the first penicillin-resistant S. aureus strain was isolated in a 
hospital and by the early 1950s and 1960s, penicillin-resistant strains became pandemic 
in the community (Chambers and DeLeo 2009; Deurenberg and Stobberingh 2008). 
Infections caused by the time were due to S. aureus clone known as phage-type 80/81 
that has been successfully eradicated after the introduction of methicillin in 1960 
(Chambers and DeLeo 2009). Again, soon S. aureus has gained resistance to methicillin 
in the first report of isolation in a hospital in UK in 1961 (David and Daum 2010).  
Resistance against methicillin, which was identified more than 20 years later, was due to 
the mecA gene that codes for a low affinity penicillin-binding protein (PBP2a). The 
mechanism of resistance was different from that against penicillin since no drug-
inactivation was observed (Chambers and DeLeo 2009).  
 Today, MRSA is becoming a major public health threat with some clones 
predominating specific geographical areas, while others achieving a pandemic spread 
(Monecke et al. 2011). The increased biological diversity of MRSA has enabled 
exploitation of the small and relatively controllable ecological niches outside hospital 
settings, which has increased the costs of infection prevention and control measures 
worldwide (Monecke et al. 2011). CA-MRSA is becoming well adapted to the 
community and is causing unexpected cases of diseases. Therefore, new 
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countermeasures against the evolving threat should be considered and designed 
(Yamamoto et al. 2010).  
2.3 Pathogenesis of Staphylococcus aureus 
 Illness caused by S. aureus is attributable to a variety of cell surface and secreted 
virulence factors that elicit host immune responses (Argudin et al. 2009). These include 
proteins, adhesins, toxins, hemolysins, superantigens and leukocidins (Chi et al. 2010; 
Haveri et al. 2008).  
Following introduction into the host, S. aureus’ surface proteins including 
fibrongen-, fibronectin- and collagen-binding proteins recognizes host matrices and 
promote bacterial colonization and adherence constituting initial stages of infection 
(Haveri et al. 2008). Upon successful adherence, the bacterium seeks survival by 
obtaining nutrients and dissemination through the production of a variety of enzymes 
and toxins responsible for the pathological events observed during infection 
development. These include hemolysins (α, β, γ, and δ) and leukocidins such as Panton-
Valentine Leukocidin (PVL) that promote host cell lysis. PVL, which is a prophage-
encoded bi-component pore-forming protein, is associated mainly with CA-MRSA 
strains. It is encoded by two genes: lukS-PV and lukF-PV residing in genomes of some 
bacteriophages (e.g.: ΦSa2958, ΦSa2MW, ΦPVL) and these are readily transferrable 
following selective bacterial infection (Boakes et al. 2011). At elevated concentrations, 
PVL causes host cell lysis; however at lower concentrations, PVL primes neutrophils to 
release inflammatory mediators such as leukotriene B4, IL-8, granule contents and 
reactive oxygen species (Chambers and DeLeo 2009). Although its role in pathogenicity 
remains controversial, many murine-conducted studies show the role of PVL in 
mitochondrial inactivation and apoptosis as well as its association with certain 
established diseases such as necrotizing pneumonia and skin and soft tissue infections 
(SSTIs) (David and Daum 2010). 
 Burden of S. aureus is associated also with production of superantigen toxins 
(SAgs) that stimulates host’s defenses leading to lethal consequences in the course of 
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rapid progression of infection (Haveri et al. 2008). Pyrogenic toxins such as toxic shock 
syndrome toxin 1 (TSST-1) and staphylococcal enterotoxins (SEs) are responsible for 
establishing toxic shock syndrome (TSS) and other related infections through T-cell and 
macrophage activation causing massive, uncontrollable release of pro-inflammatory 
cytokines (Argudin et al. 2009; Fey et al. 2003).  
Exofoliative toxins (ETA, ETB and ETD) are serine proteases that are capable of 
digesting desmoglein 1 in stratum granulosum resulting in an exfoliated epidermis. Both 
ETA and ETB cause staphylococcal scalded skin syndrome (SSSS) in infants and 
bullous impetigo in children, while ETD not only cause bullous impetigo but also deep 
pyoderma in adults (Nishifuji et al. 2008).  
Additionally, protein A which is a cell-surface associated protein represents an 
important virulence factor for S. aureus. It has the ability to bind the Fc portion of 
immunoglobulin G (IgG) by that inhibiting opsonization and subsequent phagocytosis. It 
is also associated with initiating a cascade of pro-inflammatory responses in human 
airway epithelial cells through activating tumor necrosis factor receptor 1, B cells and 
other lignads (David and Daum 2010).  
2.4 Biofilm formation by Staphylococcus aureus 
 Pathogenesis of S. aureus is also attributable to the formation of biofilms which 
help the bacterium persist and withstand hostile environments within the host 
(Dhanawade et al. 2010). Biofilms are not mere aggregations of bacteria accumulated on 
a surface, but rather are large, complex and organized communities that allow inter-
bacterial interactions and serve as transportation networks (Goodman et al. 2011). 
Biofilm formation is a multi-step process initiated by first adhering to a biotic or abiotic 
surface with the aid of specific adhesins, collectively known as microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMS). Following 
attachment, bacteria stick to each other and produce extracellular polymeric substances 
(EPS) with or without the incorporation of host components to develop a mature biofilm 
(Croes et al. 2009). EPS accounts for 90% of the actual dry mass of the biofilm and 
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creates a semi-permeable barrier that not only control entry of essential metabolites but 
also protects resident bacteria against effectors of the immune system as well as applied 
therapeutic regimens (Goodman et al. 2011). A major component in constructing 
biofilms is the polysaccharide intercellular adhesin (PIA), also referred to as poly-N-
acetylglucosamine (PNAG), a β-1,6-N-acetylglucosamine polymer, synthesized by N-
acetylglucoamyl transferase encoded by the A gene in the ica operon. ica operon 
contains also a regulatory element of three other genes (B, C and D) along with a 
transposable element, IS256, which controls expression of the icaADBC genes by 
excision or insertion at different locations on the operon (Diemond-Hernández et al. 
2010). Co-expression of the icaD along with icaA is thought to increase the activity of 
the transferase enzyme. icaB gene product is in charge of deacetylating growing PIA, 
while icaC product is responsible for externalization and elongation of the maturing 
polysaccharide (Diemond-Hernández et al. 2011). Biofilm formation however is not 
restricted to the production of PNAG, since isolation of PNAG-deficient strains where 
found to exhibit strong biofilm ability. The presence of extracellular DNA (eDNA) as 
well as proteinaceous adhesins may contribute to the establishment of biofilms (Izano et 
al. 2008). As it has been shown that regulatory pathways for biofilm formation varies 
among strains, it is important to examine if these differences can also be linked to 
differentness in clonal lineages (Croes et al. 2009). 
2.5 Resistance to methicillin 
 In 1961, shortly after the introduction of methicillin into clinical practice against 
penicillin-resistant S. aureus strains, isolation of the first methicillin-resistant strain was 
reported in the United Kingdom (David and Daum 2010). Compared to pencillinase-
mediated that has a narrow resistance spectrum, methicillin-resistant strains are 
accompanied with a broad β-lactam antibiotic class resistance and are frequently 
resistant to antibiotics from other classes (Chambers and DeLeo 2009; Blanc et al. 
2007). MRSA is considered among the most prevalent antibiotic-resistant pathogen in 
hospital settings (Mollema et al. 2010) but has clearly showed the ability for causing 
outbreaks in the community suggesting a major epidemiological evolution (Beaume et 
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al. 2010).  MRSA carriage among asymptomatic people is considered a prerequisite for 
most MRSA infections and aid in the spreading of the organism within health care as 
well as community settings (Mollema et al. 2010). Compared to hospital-acquired 
MRSA (HA-MRSA) and MSSA, infections caused by CA-MRSA are considered the 
most lethal and tend to have worst clinical outcomes (Chambers and DeLeo 2009).  
 Expression of methicillin resistance is mediated by the mecA gene that codes for 
the penicillin binding protein PBP2a, a protein with low affinity to β-lactam antibiotics 
(Ghaznavani-Rad et al. 2010). The mecA gene resides on a heterogeneous genetic 
mobile element carried by a staphylococcal chromosome known as staphylococcal 
cassette chromosome mec (SCCmec) elements (Kader et al. 2011). SCCmec elements 
share common features and these include: (i) integration in the orfX gene at a specific 
bacterial chromosomal attachment site (attBSCC) through recognition of a specific 
nucleotide sequence known as the integration site sequence of SCC (ISS) (Chen et al. 
2010); (ii) flanking repeated nucleotide and inverted complementary sequences (Kader 
et al. 2011); (iii) presence of two essential genetic elements: the mec gene complex 
(central of methicillin resistance), and the cassette chromosome recomibnase (ccr) gene 
complex (accounting for the motility of SCCmec element and surrounding sequences) 
(Kondo et al. 2007; Chen et al. 2010). In S. aureus, three major mec complexes have 
been identified known as classes A-C of which three major allotypes (ccrAB1- ccrAB3) 
with one sporadic allotype (ccrAB4) exists and a newly identified ccr gene complex 
containing only one gene (ccrC) (Kader et al. 2011). SCCmec elements can be further 
differentiated based upon three “junkyard” (J) regions: J1 region: between the ccr gene 
complex and the right flanking chromosomal region, J2 region: joining ccr gene 
complex to the mec gene complex, and J3 region: region between the ccr gene complex 
and the left flanking chromosomal region (Kondo et al. 2007). To date, at least eight 
major SCCmec types have been identified I-VIII based on the combination of class 
mecA gene complex and the type of the ccr gene complex (Smyth et al. 2011) while 
variations in the J regions are utilized to define SCCmec subtypes (Ishihara et al. 2010).  
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2.6 Molecular typing of Staphylococcus aureus 
 The prevalence and rapid dissemination of MRSA after introduction of 
methicillin into clinical use had paved the way for the appearance of hospital multi-
resistant clones, an increasingly growing concern as it is a leader cause for nosocomial 
infections all over the world (Strommenger et al. 2008). Recently, the emergence of CA-
MRSA and its potential risk for introduction into hospitals is a threat to the public health 
(Ghaznavani-Rad et al. 2010). For that, knowledge about epidemiologically prevalent 
MRSA clones is indispensable to limit their spread, determine their mode of 
pathogenicity as well as to optimize their treatment (Dauwalder et al. 2008). Numerous 
typing methods are currently available to assess strain relatedness in terms of global 
evolution and genetic clonality, the key for monitoring the evolutionary process  
responsible for the emergence and the geographical spread of clones (Hall et al. 2009; 
Dauwalder et al. 2008). Thus it’s important to have access to specific and precise typing 
methods that offer cost-effective intervention and prevention strategies (Conceiçáo et al. 
2009). It is noteworthy also that typing techniques must not only be accurate but also 
time-limiting for the continous survellinace and outbreak investigations of pandameic 
clones (Church et al. 2011). The current avaliable methods used for typing S. aureus 
include  SmaI macrorestriction using pulsed-field gel electrophoresis (PFGE), 
sequencing of seven houskeeping genes with multi-locus sequence typing (MLST), 
sequencing of protein A (spa typing) and SCCmec typing, the key for defning MRSA 
type. Each of these methods offer advantages and disadvantages regarding typeability, 
reproducibility, rapidity, discriminatory power, ease of use and interpretation as well as 
cost (Singh et al. 2006). 
2.6.1 Pulsed-field gel electrophoresis (PFGE) 
 PFGE using SmaI is considered the “gold standard” for typing MRSA isolates 
(Church et al. 2011; Bosch et al. 2010; Faria et al. 2008; Malachowa et al. 2005). This 
technique, which was developed by Schwarz and Cantor (1984), involves growing the 
organism in a broth or solid media combined with low melting agarose forming plugs 
containing the whole bacteria. Embedded organisms are then exposed to in situ lysis and 
 10 
 
digestion using an infrequently cutting restriction endonuclease (Olive and Bean 1999). 
SmaI (5’-CCC^GGG-3’) hexanucleotide recognition sequence rarely cuts the A + T rich 
gram positive bacteria, thus it has been shown to have the highest performance for S. 
aureus (Goering 2010). The resulting series of fragments is of different sizing patterns 
and are referred to restriction fragment length polymorphisms (RFLPs) (Singh et al. 
2006). These fragments are, however, too large to be separated by conventional 
electrophoresis. Thus, alternative methods, generally defined as PFGE, rely on time-
associated size-dependent reorientation of DNA migration by switching the direction of 
an electrical current in a predetermined pattern (Goering 2010). One common approach 
utilized by PFGE is contour-clamped homogenous electric field (CHEF) that contains 
multiple electrodes for switching electric field at 120˚ angles ensuring efficient 
separation (Singh et al. 2006). In order to interpret the resulting DNA fragment patterns 
and transform them into potentially meaningful information in an epidemiological text, 
guidelines proposed by Tenover et al. (1995) involves comparison of bacterial isolates to 
obtain their genomic relatedness (Goering 2010). Accordingly, banding patterns that 
differ in three fragments is probably the result of a single genetic event and thus isolates 
are classified as epidemiologically related subtypes of the same strain, while isolates that 
differs in the position of more than three restriction fragments are considered to be 
unrelated (Singh et al. 2006). Today, softwares are accessible for analyzing DNA 
fingerprint data as well as creating databases by storing banding patterns for a series of 
gels. The resulting phylogenic output is referred to as a dendrogram, a graphical 
representation of genetic similarities and differences between groups (Singh et al. 2006). 
Although PFGE is highly reproducible and stays an important tool in micro- and macro-
epidemiological surveys, the technique suffers from several disadvantages. These 
include: high cost in outbreaks, technical challenge, time consumption, labor 
intensiveness, complex inter-laboratory exchange of results, as well as hampered 
typeability of isolates having methylated SmaI sites (Church et al. 2011; Bosch et al. 
2010; Georing 2010; Hallin et al. 2007). 
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2.6.2 Multi-locus sequence typing (MLST) 
 Accurate determination of genetic relatedness among bacterial isolates 
constitutes the basics of epidemiological and evolutionary studies. Recent nucleotide-
sequencing methodologies at multiple housekeeping loci is increasing and offers 
advantages in inferring strain relatedness as well as reconstructing evolutionary events 
(Feil et al. 2004). Characterization of S. aureus isolates have been determined by 
scanning sequences of approximately 450 bp internal fragments of seven housekeeping 
genes using MLST. The technique which was developed by Enright et al. in 2000, offers 
high discriminatory power in indexing slowly accumulated variations that serves in 
long-term global epidemiological studies (Enright et al. 2002). The seven housekeeping 
genes are: carbamate kinase (arcC), shikimate dehydrogenase (aroE), glycerol kinase 
(glpF), guanylate kinase (gmk), phosphate acetyltransferase (pta), triosephosphate 
isomerase (tpi) and acetyl coenzyme A acetyltransferase (yqiL) (Deurenberg and 
Stobberingh 2008). The combination of alleles at the seven loci is defined as an allelic 
profile which is assigned a unique sequence type (ST). Studying the evolutionary events 
between isolates using MLST reveals that a significant proportion of isolates belong to a 
confined number of clusters that share related genotypes, commonly referred to as clonal 
complexes (CCs) (Feil et al. 2004). Implementation of algorithms such as the based 
upon related sequence type (eBURST) algorithm (www.eburst.mlst.net) to cluster 
isolates into CCs is based on determining a similarity threshold for group definition such 
as applying the stringent method with defining six out of seven housekeeping genes as 
identical and thus clustering isolates into a single CC (Deurenberg and Stobberingh 
2008). Clonal complexes are thus composed of a prevalent genotype among less 
common relatives of this genotype where the putative ancestor of the CC is the ST with 
the largest number of single locus variants (SLVs) (Deurenberg and Stobberingh 2008; 
Feil et al. 2004). MLST is proven to be a useful technique for molecular evolution 
studies due to ease of performance as well as providing fast, unambiguous and portable 
data that are exchanged easily due to the presence of available public databases 
(Conceiçáo et al. 2009; Hallin et al. 2007). However, still MLST could not be useful in 
local outbreaks due to its high cost, labor intesivness and time consumption 
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(Strommenger et al. 2006; Deurenberg and Stobberingh 2008). Combintaion of both 
MLST and SCCmec typing data is indispensible for determining the nomeneclature of 
endemic MRSA clones (Hallin et al. 2007; Enright et al. 2002). 
2.6.3 spa typing  
spa typing is an efficient and highly discriminatory genetic marker that is able to 
epidemiologically characterize S. aureus species and identify closely related ancestral 
isolates. The spa locus of S. aureus codes for S. aureus protein A (Spa), a 42 KDa anti-
phagocytic protein known for its binding capacity to the Fc portion of IgG (Shakeri et al. 
2010). The signal sequence (S region) in the N-terminal part of the Spa protein contains 
five highly homologous IgG-binding units: E, D, A, B and C, each contains 
approximately 58 amino acids (Baum et al. 2009; Shakeri et al. 2010). On the other 
hand, the C-terminal part (also known as the X region) consists of two domains: (i) 
conserved region XC that binds S. aureus’ cell wall via the LPXTG-binding motif and 
(ii) repeat region XR consists of highly polymorphic internal variable region of 24-27 bp 
short tandem repeats, which vary not only in number but also with the sequence of the 
individual repeat units (Baum et al. 2009; Grundmann et al. 2010). Determining the 
sequence polymorphism in the variable X region constitutes the basis of spa typing. 
Thus, the combination of the different repeats is assigned to a unique spa type 
designated by lower case “t” followed by a number. spa types are then clustered into spa 
complexes (spa-CCs) using based upon repeat pattern (BURP) algorithm that group 
clonal relatedness of strains on the basis of repeat duplication/deletion and point 
mutation events (Strommenger et al. 2006). This single locus sequence-based technique 
provide portable, unambiguous and biologically meaningful molecular typing data, 
which have demonstrated their utility for epidemiological purposes such as transmission 
and outbreak investigations at various geographical levels. 
 
2.6.4 SCCmec typing: 
 Complete characterization of MRSA lineages depends not only on identifying 
the bacterial genetic background bust also on molecular characterization of the mobile 
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genetic element (SCCmec), responsible for carrying drug resistance determinant mecA 
(Olivera and de Lencastre 2002; Chmelnitsky et al. 2007). For SCCmec type 
determination, several suggested multiplex PCRs have been developed that require lots 
of optimization and do not always generate concordant data (Ghaznavani-Rad et al. 
2010). To date, at least eight major SCCmec elements (I-VII) has been identified based 
on the combination of mec and ccr sequence complexes (Zhang et al. 2009) with reports 
identifying up to eleven types (I-XI) (Zong et al. 2011). SCCmec elements range in size 
between 21-67 kb (Chambers and DeLeo 2009) with large SCCmec elements types I-III 
mostly associated with HA-MRSA infections whilst the smaller elements types IV-VI 
are commonly associated with CA-MRSA infections (Wang et al. 2010; David and 
Daum 2010; Valsesia et al. 2010; Smyth et al. 2011). CA-MRSA strains have evolved 
rapidly in the community since they have acquired the small SCCmec elements which 
contain mecA gene with or without additional resistant genes and thus are more mobile 
and disseminate easily among the community. On the other hand, large SCCmec types II 
and III elements contain additional junkyard regions for insertion of genes conferring 
resistance to non-β-lactam antibiotics and are thus associated with strains having multi-
drug resistance (MDR) phenotypes (Zhang et al. 2005; David and Daum 2010). The 
developed MRSA nomenclature scheme, suggested by the International Union of 
Microbiology Societies, uses the data of both MLST and SCCmec typing, defined as the 
“clonal type”, for reporting circulating MRSA clones (Hallin et al. 2007; Zhang et al. 
2005). 
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CHAPTER THREE 
MATERIALS AND METHODS 
 
3.1 Clinical isolates  
Between May 2011 and October 2011, a total of 132 non-duplicate S. aureus 
samples were kindly provided by Dr. George Araj from the American University of 
Beirut Medical Center (AUB-MC). Table 1 demonstrates number of isolates in terms of 
origin of the specimen. All isolates were confirmed as S. aureus by growth on mannitol 
salt agar (MSA), gram staining, positive catalase reaction, as well as ability to produce 
coagulase enzyme using SLIDEX
®
 Staph Plus agglutination kit (Biomérieux, France). 
The samples were streaked on Tryptone Soy Agar (TSA) and stored in Cryobanks at -
80°C. The isolates were designated by HST 001-132. 
Table1. Demographic distribution of isolates in terms of specimen origin 
Specimen Origin # Found in Isolates (%) 
Wound/ cyst/ abscess 53 (40) 
Respiratory 38 (29) 
Eye 6 (5) 
Blood 2 (2) 
Catheter 2 (2) 
Urine 1 (1) 
Others
† 
30 (21) 
† Others: nose, joint fluid, aspirates, throat, drainage, pleural fluid, ear 
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3.2 DNA Extraction 
Isolates were grown overnight on TSA at 37°C. DNA extraction was done using 
Nucleospin
®
 Tissue (Macherey-Nagel, Germany) according to manufacturer’s 
instructions. The lysates were then stored at -20°C until needed. 
3.3 16S rDNA, PVL, mecA genes amplification  
Polymerase chain reaction (PCR) assays were performed on a PerkinElmer 
GeneAmp 9700 thermal cycler (PerkinElmer, Wellesly, Massachusetts). Amplification 
of the 16S rRNA, PVL and mecA genes were done using primers described by McClure 
et al. 2006 (Table 2). The amplification reaction contained 1.5µl of template DNA in a 
final volume of 25µl containing 0.4, 0.8 and 0.8µM for the primers specific for the 16S 
rRNA, lukS-PV, and mecA genes respectively with 2U of AmpliTaq Fermentas, 
1.5mmol.l
-1
 MgCl2, 1.6X Taq buffer, 0.2mM of each deoxynucleoside triphosphate 
(dNTP). The thermocycling conditions were set at 94°C for 5min followed by 10 cycles 
of 94°C for 45s, 55°C for 45s, and 72°C for 75s and 25 cycles of 94°C for 45s, 50°C for 
45s, and 72°C for 75s and finally soaked at 20°C. The expected PCR amplicons were 
756, 433, and 310 bp for the 16S rRNA, lukS-PV, and mecA gene respectively. The 
fragments were visualized by 7µl of ethidium bromide staining using 1.5% agarose gel 
using with 1x Tris-Acetic Acid-EDTA (TAE) buffer at 100V.  
Table2. Primers used for the amplification of the 16S rRNA, PVL and mecA genes. 
Primer Orientation Oligonucleotide sequence (5’→3’) Product Size (bp) 
Staph 756 
Forward 
Reverse 
AACTCTGTTATTAGGGAAGAACA 
CCACCTTCCTCCGGTTTGTCACC 
756 
LUK-PV 
Forward 
Reverse 
ATCATTAGGTAAAATGTCTGGACATGATCCA 
GCATCAAGTGTATTGGATAGCAAAAGC 
433 
MecA 
Forward 
Reverse 
GTAGAAATGACTGAACGTCCGATAA 
CCAATTCCACATTGTTTCGGTCTAA 
310 
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3.4 Typing of the spa locus 
3.4.1 Pre-sequencing PCR 
Typing of the Staphylococcus protein A (spa) locus was carried by first 
amplifying the spa gene as described previously (Harmsen et al. 2003; Strommenger et 
al. 2008). The amplification employed 20pmol of the spa-1-for (5'- TAA AGA CGA 
TCC TTC GGT GAG C -3') and 20pmol of spa-1-rev (5'-CAG CAG TAG TGC CGT 
TTG CTT -3') primers in a 20μl mixture containing 2μl DNA, 200μM dNTPs, 5μl of 10-
fold concentrated PCR Buffer II (Applied Biosystems), MgCl2 1.5mM, and 1.25U of 
AmpliTaq DNA polymerase (Applied Biosystems). Thermal cycling reactions consisted 
of an initial denaturation (12min at 95°C) followed by 30 cycles of denaturation (30s at 
94°C), annealing (30s at 60°C), and extension (60s at 72°C), with a single final 
extension (10min at 72°C). The resulting DNA fragments were visualized by 7µl of 
ethidium bromide staining on 1% agarose gel using 1X TAE buffer at 100V. 
3.4.2 EXOSAP-IT 
To purify the pre-sequencing PCR products, 4µl of EXOSAP-IT (usb
®
) enzyme 
was added to 10µl of the PCR products. The reactions consisted of 37°C for 30min, 
80°C for 15min and stored at 20°C. 
3.4.3 Sequencing PCR 
The amplicons previously spa-typed were sequenced using the ABI Prism 
BigDye Terminator v3.0 Ready Reaction Cycle Sequencing Kit (Applied Biosystems). 
The sequencing reaction was conducted using 4μl of 5X diluted Bigdye® (Applied 
Biosystems) premix, 3µl of 1.2µM sequencing primer, and 3μl of the cleaned PCR 
product in a total volume of 10μl. PCR cycling consisted of initial denaturation step at 
96˚C for 1min followed by 26 cycles of denaturation (96˚C for 1s), annealing (50˚C for 
5s) and extension (60˚C for 4min). 
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3.4.4 DNA Precipitation and Loading 
The sequencing products were purified using DyeEx
®
 2.0 Spin Kit (Qiagen, 
Hilden, Germany). The samples were dried in a vacuum centrifuge, and then 10μl of 
HiDi formamide were added (Applied Biosystems) as loading media for sequencing 
electrophoresis on an ABI 3500 Genetic Analyzer. The software Ridom StaphType
TM
 v 
2.2.1 (Ridom GmbH, Würzburg, Germany) was used for spa sequence analysis. 
3.5 MLST 
       For amplification of the seven housekeeping genes, a PCR was performed in a total 
volume of 20μl using the 7 housekeeping genes primers for amplification as described 
by Enright et al. 2002 (Table 3). The reaction contained 2μl DNA, 200μM dNTPs, 
10pmol of each primer, 5μl of 10-fold concentrated PCR Buffer II (Applied 
Biosystems), MgCl2 1.5mM, and 1.25U of AmpliTaq DNA polymerase (Applied 
Biosystems). Thermal cycling reactions consisted of an initial denaturation (12min at 
95°C) followed by 30 cycles of denaturation (30s at 94°C), annealing (30s at 55°C), and 
extension (60s at 72°C), with a single final extension (10min at 72°C). The bands were 
visualized by ethidium bromide staining on 1% agarose gel using 1X TAE buffer.  
MLST types were assigned by submitting the sequences to the S. aureus database on the 
website (http://www.mlst.net/) and eBURST v3 software was used for MLST sequence 
analysis and clustering. 
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   Table3. Primers used for the amplification of the seven housekeeping genes. 
Primer Orientation Oligonucleotide sequence (5’→3’) 
arcC Forward 
Reverse 
ATTCACCAGCGCGTATTGTC 
AGGTATCTGCTTCAATCAGCG 
aroE Forward 
Reverse 
ATCGGAAATCCTATTTCACATTC 
GGTGTTGTATTAATAACGATATC 
Glp Forward 
Reverse 
CTAGGAACTGCAATCTTAATCC 
TGGTAAAATCGCATGTGCAATTC 
gmk Forward 
Reverse 
ATCGTTTTATCAGGACCATCTG 
TCATTAACTACAACGTAATCGTA 
Pta Forward 
Reverse 
GTTAAAATCGTATTACCTGAAGG 
GACCCTTTTGTTGAAAAGCTTAA 
Tpi Forward 
Reverse 
TCGTTCATTCTGAACGTCGTGAA 
TTTGCACCTTCTAACAATTGTAC 
yqiL Forward 
Reverse 
CAGCATACACACCTATTGGC 
CGTTGAGGAATCGATACTGGAAC 
 
3.6 PFGE 
Isolates subjected to MLST typing were also typed using PFGE technique to 
reveal a banding pattern on the gel. PFGE was done according to Georing and Winters 
(1992) with some modifications. In brief, after suspending the pellet with TEN buffer 
followed by EC buffer, samples were held at 55°C for about 10min. A 2.0ml aliquot 
suspension was then mixed with 0.5ml low melting agarose (GE Healthcare) and 25µl 
Lysostaphin (2mg/ml [Sigma]). Inserts were then casted and left to harden for 10-15min 
and then placed in 4ml EC buffer and 10-15µl RNase and incubated at 37°C for at least 
2h. EC buffer is then decanted and replaced by 4mL TE buffer and 20µL Proteinase K 
and left overnight at 50˚C. A small slice was cut and the remaining of the plug was 
stored at 4˚C for later usage. The slice was soaked in 500µL 1x buffer A (Roche) and 
washed for 30min at 4˚C. The process was repeated 4x with prepared 10X buffer A and 
kept overnight at 4˚C. The buffer was discarded and replaced with a fresh 200µL 1x 
buffer A (Roche) and 1µL of 5000U SmaI enzyme and incubated for 4h at 25˚C in a 
thermoblock. The slice was then washed twice with 200µL 0.1x buffer A (Roche) for 
15min each time to finally stop the reaction with 20µL of stop mix (0.25% bromophenol 
blue and 0.1% SDS), and stored at 4˚C. The bands were resolved with a 1% agarose gel 
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in 0.5x Tris-Boric Acid-EDTA (TBE) and run in the CHEF-DRIII System 
electrophoresis apparatus (Bio-Rad, Hercules, CA) using 0.5x TBE with an initial time 
5s and a final time 50s at 14
˚
C for 23.5hrs. The bands were then visualized under UV 
(SYNGENE-G:box) after staining with EtBr. Cluster analysis was performed with 
GelCompar II
®
 software (Applied Maths, Sint-Martens-Latem, Belgium) using dice 
coefficient and visualized as a dendogram by the unweighted pair group method 
(UPGMA), using average linkages with 1% tolerance and 1% optimization settings. A 
similarity cutoff of 80% was used to define a cluster. 
3.7 SCCmec subtyping 
The conditions for the multiplex PCR assay were first optimized
 
by using the 
following reference strains NCTC 10442, N315, 85/2082, JCSC 4744, JCSC 217, JCSC 
47882 and WIS as described by Ito et al. (2001) and Zhang et al. (2005). The protocol was 
adapted from Zhang et al. 2005. The optimal cycling
 
conditions were the following: 95°C 
for 15min; 30 cycles
 
of 94°C for 30s, 57°C for 1.5min, and 72°C for 1.5min; and a final 
extension at 72°C for 10min. For multiplex PCR, a Qiagen
®
 multiplex PCR kit was used. 
Reaction mixtures contained 1µg of chromosomal
 
template; 25µl master mix with 3mM 
MgCl2, 5µl primer mix (2mM in TE buffer for each primer) and RNase-free water to a 
final volume of 50µl. The PCR products (7µl)
 
were resolved in a 1.8% (w/v) Metaphor 
(Lonza, Rockland, ME, USA) agarose
 
gel in 0.5% Tris-borate-EDTA buffer (Bio-Rad, 
Hercules, CA)
 
at 80V/cm for 1h and were visualized with ethidium bromide. Table 4 
summarizes the PCR primer sets selected based on specificity, compatibility and ability to 
target fragments of SCCmec types I–V (Zhang et al. 2005; Ito et al. 2001).   
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Table4. Primers used for the simultaneous identification of SCCmec elements of MRSA by multiplex PCR as 
described by Zhang et al. 2005 
Primer 
 
Orientation Oligonucleotide sequence (5’→3’) Product Size (bp) 
Type I Forward 
Reverse 
GCTTTAAAGAGTGTCGTTACAGG 
GTTCTCTCATAGTATGACGTCC 
613 
Type II Forward 
Reverse 
CGTTGAAGATGATGAAGCG 
CGAAATCAATGGTTAATGGACC 
398 
Type III Forward 
Reverse 
CCATATTGTGTACGATGCG 
CCTTAGTTGTCGTAACAGATCG 
280 
Type IVa Forward 
Reverse 
GCCTTATTCGAAGAAACCG 
CTACTCTTCTGAAAAGCGTCG 
776 
Type IVb Forward 
Reverse 
TCTGGAATTACTTCAGCTGC 
AAACAATATTGCTCTCCCTC 
493 
Type IVc Forward 
Reverse 
ACAATATTTGTATTATCGGAGAGC 
TTGGTATGAGGTATTGCTGG 
200 
Type IVd Forward 
Reverse 
CTCAAAATACGGACCCCAATACA 
TGCTCCAGTAATTGCTAAAG 
881 
Type V Forward 
Reverse 
GAACATTGTTACTTAAATGAGCG 
TGAAAGTTGTACCCTTGACACC 325 
MecA147 
 
Forward 
Reverse 
GTGAAGATATACCAAGTGATT 
ATGCGCTATAGATTGAAAGGAT 
147 
mecI 
 
Forward 
Reverse 
CCCTTTTTATACAATCTCGTT 
ATATCATCTGCAGAATGGG 
146 
IS1272 
mecR1 
Forward 
Reverse 
TATTTTTGGGTTTCACTCGG 
CTCCACGTTAATTCCATTAATACC 
1,305 
ccrAB-β2 
ccrAB-α2 
ccrAB-α3 
ccrAB-α4 
Forward 
Reverse 
Reverse 
Reverse 
ATTGCCTTGATAATAGCCITCT 
AACCTATATCATCAATCAGTACGT 
TAAAGGCATCAATGCACAAACACT 
AGCTCAAAAGCAAGCAATAGAAT 
 
700 
1,000 
1,600 
ccrC Forward 
Reverse 
ATGAATTCAAAGAGCATGGC 
GATTTAGAATTGTCGTGATTGC 
336 
 
3.8 Antibiotic susceptibility testing 
 All 132 S. aureus isolates were tested against antibiotic resistance by the Kirby-
Baüer disk diffusion method according to the recommendations of the Clinical and 
Laboratory Standards Institute (CLSI), 2010. Isolates were streaked on Müeller-Hinton 
agar (Oxoid) and incubated at 37˚C for 24hrs with the following antibiotics: augmentine, 
cephalothin, ciprofloxacin, clindamycin, erythromycin, teicoplanin, tetracycline, 
trimethoprim-sulfamethaxole, gentamicin, ampicillin and rifampin. Isolates collected 
from urine were tested additionally against nitrofurantoin and norfloxacin. Table 5 
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summarizes the zone of inhibition (ZOI) for each antibiotic along with the concentration 
(µg) as recommended.  
Table5. Zone of inhibition (mm) for the tested antibiotics according to CLSI, 2010 
 
 
 
 
 
 
 
 
 
 
 
 
Antibiotic (µg) 
ZOI (mm)  
Antibiotic (µg) 
ZOI (mm) 
S I R S I R 
Cephalothin (30) 18 15-17 14 Tetracycline (30) 19 15-18 14 
Ciprofloxacin (5) 21 16-20 15 SXT (1.25/3.75) 16 11-15 10 
Clindamycin (2) 21 15-20 14 Rifampin (5) 20 17-19 16 
Erythromycin (15) 23 14-22 13 Cefoxitin (30) 22 __ 21 
Teicoplanin (30) 14 11-13 10 Gentamicin (10) 15 13-14 12 
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CHAPTER FOUR 
RESULTS 
4.1 16S rRNA, PVL, mecA genes amplification 
All 132 S. aureus isolates were confirmed to be Staph through the amplification 
of the 16S rRNA gene and tested for being MSSA or MRSA and being PVL positive or 
not through testing mecA and lukS/F-PV genes respectively. Accordingly, triplex PCR 
assay may yield 3, 2 or 1 band/s. The first band of 756bp size corresponds to the partial 
amplification of the 16S rRNA and must be present for all Staphylococcus isolates. The 
second band is a 433bp band that corresponds to the amplification product of the PVL 
gene. The third band is a 310bp band that corresponds to the amplification product of the 
mecA gene (Figure 1). Table 6 summarizes the results of the triplex PCR for all 132 
isolates showing that 29.5% (39 samples) of the isolates were MRSA and 70.5% (93 
samples) were MSSA. 100 isolates were PVL negative (75.8%) and the remaining 
24.2% (32 isolates) were PVL positive.  
  
Fig1. Agarose gel electrophoresis showing representative PCR products after 16S rRNA, PVL & mecA genes 
amplification. The first lane shows 100bp DNA marker (Fermentas); lanes 1-8 show PCR products of the three 
genes of different isolates. Lane 9 is the negative control. 
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Table6. Distribution of isolates among MRSA and MSSA, PVL positive and PVL negative  
Organism Number of Isolates (%) 
MSSA 
                     PVL positive 
                     PVL negative 
93 (70.5) 
11 (11.8) 
82 (88.2) 
MRSA 
                     PVL positive 
                     PVL negative 
39 (29.5) 
21 (53.8) 
18 (46.2) 
 
4.2 SCCmec typing 
SCCmec subtyping for MRSA isolates showed the predominance of SCCmec 
typeIV (85%) followed by typeV (13%) (Figure2).  
 
Fig2. Distribution of SCCmec types among MRSA isolates. Type IV shows the highest percentage (85%).  
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4.3 spa typing 
All 132 S. aureus isolates showed bands ranging in size between 250-400bp after 
spa gene amplification (Figure 3). All isolates were typeable and analysis using Ridom 
Staph Type version 2.2.1 (Ridom GmbH, Würzburg, Germany) revealed 71 different spa 
types in this study. The most common encountered spa types were t021, t044 and t267 
representing 6%, 5% and 5% of the studied isolates, respectively (Figure 4). 53 different 
spa types were identified in the MSSA isolates compared to 25 in the MRSA isolates. The 
most common spa type within the MSSA was t021 (8%) compared to t044 (13%) within 
the MRSA isolates (Figures 5 and 6). It is noteworthy that 9 new spa types were identified 
in this study and were designated spa types: t9127, t9128, t9129, t9804, t9805, t9806, 
t9830, t9831 and t9832 with four belonging to spa CCs (two representing group founders) 
while the remaining five being singletons (Table 7). Using BURP analysis, spa types were 
clustered into 40 different groups, with 15 groups having more than one spa type and 25 
singletons (Figures 7 and 8). Clustering parameters excluded spa types with fewer than 
five repeats and groups spa types to the same spa-CC if the cost was less than or equal to 
six. Four strains were excluded (spa types t132, t380 and t386)  and out of the fifteen spa 
CCs, eight groups had designated group founders (spa CC306/002, spa CC084, spa 
CC304/121, spa CC021, spa CC186/786/690, spa CC044, spa CC032 and spa CC267). 
spa CC084 as well as five clusters with no founder had comprised only MSSA strains. 
MRSA isolates belonging to spa CC032 and spa CC044 all harbored SCCmec type IV, 
while those belonging to spa CC186/786/690 and spa CC304/121 had SCCmec type IVa 
and those belonging to spa CC267 harbored SCCmec type V. 
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Fig3. Agarose gel electrophoresis showing representative PCR products after spa amplification. The first lane shows 
100bp DNA marker (Fermentas); lanes 1-21 show PCR products of the amplified spa gene with sizes between 250bp 
and 400 bp 
 
Table7. Ridom repeat succession for the novel 9 spa types detected in this study.  
Ridom spa Type # of Isolates mecA PVL Ridom Repeat Succession spa-CC  
t9804 1 MSSA Neg. 08-16-34-02-43-34-16-16-34-02-16 Singletons 
t9805 2 MSSA 
MSSA 
Pos. 
Neg. 
26-22-10-17-20-17-12 
Singletons 
t9806 1 MSSA Neg. 7-17-12-23-02-12-23 No founder 
t9127 1 MSSA Neg. 07-23-12-34-34-12-36-23-02-12-23 84 
t9128 1 MSSA Neg. 26-23-34-23-31-05-17-17-25-16-28 Singletons 
t9129 1 MSSA Neg. 7-16-21-17-34-34-34-33-34 267 
t9830 1 MSSA Neg. 04-17-34-17-32-23-24-24 Singletons 
t9831 2 MRSA Neg. 07-23-12-12-20-17-12-12-12 No founder 
t9832 2 MRSA Neg. 125-13-23-31-29-25-17-25-16-28 Singletons 
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Fig4. Percentage of the 71 spa types representing all 132 isolates undertaken in this study with t021 being the 
predominant spa type (6.1%) followed by t267 and t044 (4.5% each).  
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Fig5. Percentage distribution of the different spa types in the MSSA lineage (n=93) with t021 being the predominant 
spa type (7.5%). 
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Fig6. Percentage distribution of the different spa types in the MRSA lineage (n=39) with t044being the predominant 
spa type (12.8%). 
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Fig7. Population snapshot based on BURP analysis of 132 isolates. BURP grouping using default parameters resulted 
in 15 spa CCs with 8 having group founders, 25 singletons, and 4 excluded spa types. Each dot represents a unique spa 
type. The diameter of the a dot is proportional to the quantity of the corresponding spa type. Blue dots represent 
primary group founders, defined as the spa type(s) with the highest founder score within a CC, while yellow dots 
represents major subgroup founders. 
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Fig8. Clustering spa types by BURP showing the percentage of samples belonging to each spa-CC. 
4.4 MLST 
Thirty six isolates representing all spa CCs were MLST-typed. 25 allelic profiles 
were generated in this study representing STs. There were seven major MRSA clones 
defined as isolates with the same ST and SCCmec type. These clones were associated with 
complexes CC5, CC22, CC30, CC72, CC80 and CC239. On the other hand, twenty MSSA 
clones were identified and those were associated with complexes CC1, CC6, CC7, CC8, 
CC15, CC25, CC30, CC45, CC88, CC97, CC121, CC361, CC398, CC641, CC770 and 
CC789. The predominant clones in this study were ST80-MRSA-IV (7.7%) followed by 
ST30-MSSA (6.1%) (Table 8). In order to view actual evolutionary events among the 
observed STs, sequences of the seven housekeeping genes were concatenated into a single 
sequence followed by alignment against all other sequences (Figure 9). 100% confidence 
levels were observed in STs that belong to the same MLST-CC (e.g. ST15 and ST199 
belonging to CC15, and ST30 and ST34 belonging to CC30). 99% and 95% confidence 
levels were observed in STs that share single locus variants and belong to different MLST-
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CCs (e.g. ST5 and ST641, ST789 and ST7, and ST239 and ST8). Low confidence levels 
(39%) were observed in STs that belong to different MLST-CCs (e.g. ST361 and ST80). 
 
Clone spa type (%) spa-CC PVL MLST MLST-CC 
ST5-MRSA-IV 
t002 (1.5%) 306/002 Neg. 5 5 
t214 (1.5%) 306/002 Neg. 5 5 
ST6-MSSA t304 (3%) 304/121 Neg. 6 6 
ST361-MSSA t315 (1.5%) 306/002 Neg. 361 361 
ST199-MSSA 
t084 (3%) 84 Neg. 199 15 
t9210 (0.8%) 84 Neg. 199 15 
ST15-MSSA t774 (0.8%) 84 Neg. 15 15 
ST8-MSSA t008 (1.5%) 304/121 Pos. 8 8 
ST30-MSSA 
t012 (0.8%) 21 Neg. 30 30 
t021 (5.3%) 21 Pos. 30 30 
ST30-MRSA-IV t019 (1.5%) 21 Pos. 30 30 
ST34-MSSA 
t2096 (0.8%) No founder Neg. 34 30 
t166 (1.5%) No founder Neg. 34 30 
ST80-MRSA-IV 
t021 (0.8%) 21 Neg. 80 80 
t044 (3.8%) 44 Pos. 80 80 
t131 (2.3%) 44 Pos. 80 80 
t6476 (0.8%) Singletons Pos. 80 80 
ST720-MSSA t659 (0.8%) No founder Neg. 720 121 
ST1-MSSA t127 (3.8%) Singletons Neg. 1 1 
ST22-MRSA-IV t9832 (1.5%) Singletons Neg. 22 22 
ST508-MSSA t861 (0.8%) Singletons Neg. 508 45 
ST46-MSSA t132 (1.5%) Excluded Neg. 46 45 
ST88-MSSA t186 (1.5%) 186/786/690 Neg. 88 88 
ST72-MRSA-IV t3468 (0.8%) No founder Neg. 72 72 
ST72-MRSA-V t9831 (1.5%) No founder Neg. 72 72 
ST97-MSSA 
t9129 (0.8%) 267 Neg. 97 97 
t044 (0.8%) 44 Neg. 97 97 
ST291-MSSA 
t937 (0.8%) No founder Neg. 291 398 
t1149 (3.8%) No founder Neg. 291 398 
ST7-MSSA t091 (3.8%) No founder Neg. 7 7 
ST789-MSSA t9806 (0.8%) No founder Neg. 789 789 
ST770-MSSA t377 (1.5%) Singletons Neg. 770 770 
ST641-MSSA t005 (1.5%) 32 Neg. 641 641 
ST25-MSSA t078 (0.8%) No founder Neg. 25 25 
ST239-MRSA-III t037 (0.8%) 21 Neg. 239 239 
ST1995-MSSA t349 (0.8%) No founder Neg. 1995 25 
Table8. Overview of the major MRSA and MSSA spa types and their corresponding MLST clones. 
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Fig9. Neighbor-Joining tree of the representative STs. Sequences for the variable sites from the seven housekeeping gene 
fragments were concatenated into a single sequence. 
 
4.5 PFGE 
 Selected MLST-typed samples were subjected also to PFGE typing. All 36 isolates 
were typeable by SmaI macrorestriction and produced different macrorestriction patterns 
according to the criteria defined by Tenover et al. (1995). Thirty two groups were defined 
by employing 80% similarity as cutoff with only two groups containing more than one 
isolate. Clusters were designated by numbers from 1 to 32 (Figure10).  
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Fig10. Dendrogram of PFGE clusters and genotypic relationships of S. aureus isolates. SmaI macrorestriction patterns were 
analyzed using the Dice coefficient and visualized by unweighted-pair group method, using average linkages with 1% 
tolerance and 1% optimization settings. The similarity cutoff of 80% is indicated by a vertical line. PFGE groups determined 
by cluster analysis are numbered from 1-32. spa types, spa-CC, ST type and MLST-CC are also included.  
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4.6 Antibiotic susceptibility testing 
 
Seventy five (57%) out of the 132 isolates were sensitive to all tested antibiotics. 
Among the remaining 57 isolates (43%), resistance was detected to one or more of the 
antibiotics. Results obtained showed that 14% of isolates were resistant to augmentin, 
cephalothin and oxacillin and were also shown to be methicillin-resistant. On the other 
hand, the multidrug resistant profiles within the MSSA included resistance against 
clindamycin and erythromycin (5%) in an inducible manner. It is noteworthy that all 
isolates were sensitive to teicoplanin, vancomycin and rifampin. Table 9 below 
summarizes the percentage of the 19 generated resistant profiles in this study as well as 
their distribution among MRSA and MSSA. 
 
Resistant Profile (%) # among MSSA # among MRSA 
ERY (0.7) 1 0 
TET (4.5) 5 1 
CIP (1.5) 2 0 
CLI, ERY (4.5) 6 0 
CIP, ERY (0.7) 1 0 
CIP, TET (0.7) 1 0 
CIP, CLI (0.7) 1 0 
TET, SXT (0.7) 1 0 
CLI, ERY, TET (0.7) 1 0 
KF, OXA, TET (0.7) 0 1 
AUG, KF, OXA (14.4) 0 19 
AUG, KF, OXA, TET (4.5) 0 6 
AUG, KF, ERY, OXA (0.7) 0 1 
AUG, KF, CIP, ERY, OXA (2.3) 0 1 
AUG, KF, CIP, CLI, ERY, OXA (2.3) 0 3 
AUG, KF, CLI, ERY, OXA, TET (1.5) 0 2 
AUG, KF, CIP, CLI, ERY, OXA, TET, SXT (0.7) 0 1 
AMP, AUG, KF, OXA (0.7) 0 1 
AMP, AUG, KF, OXA, TET (0.7) 0 1 
 
Table9. Percentage distribution of resistant profiles observed among MRSA and MSSA. 
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CHAPTER FIVE 
DISCUSSION 
 
In this study, 132 clinical S. aureus isolates were collected between May-October 
2011 and genotyped using different molecular techniques including SCCmec typing, spa 
typing, MLST and PFGE. Forty percent of the isolates were recovered from wound, cysts 
and abscesses which are congruent with high prevalence of SSTI infections caused by S. 
aureus (David and Daum 2010). MRSA occurrence among S. aureus varies according to 
the geographical region, with a low frequency (~1%) in some countries in Europe (e.g. 
Netherlands, Denmark and Sweden) and a high frequency (>60%) in countries such as that 
observed in US and Japan (Stam-Bolink et al. 2007; Fang et al. 2008; Larsen et al. 2008; 
Klevens et al. 2007; Tiemersma et al. 2004). The prevalence of MRSA in our study was 
moderate (29.5%) compared to previous studies done in Lebanon (January 2006-May 
2007) showing predominance of MRSA isolates (71.5%) (Tokajian et al. 2010). Although 
the role of PVL in S. aureus pathogenicity remains controversial with a number of studies 
showing its association with primary skin infections and necrotizing pneumonia, while 
others reducing its importance as a virulent factor (Brown et al. 2007; Gillet et al. 2002; 
Lina et al. 1999; Labandeira-Rey et al. 2007; Voyich et al. 2006; Bubeck Wardenburg et 
al. 2008). In our study, PVL genes were detected in 54% of MRSA and 12% of MSSA. 
Several conducted studies have shown the prevalence of PVL genes among MRSA 
compared to MSSA isolates from infections and colonization (Baggett et al. 2004; 
Martinez-Aguilar et al. 2004) with an increase in the severity of infections in PVL positive 
MSSA strains being detected (Gillet et al. 2002; Roberts et al. 2008; Salliot et al. 2006; 
Sola et al. 2007). 
SCCmec typing, which is important for defining MRSA clones, showed the 
prevalence of the mobile genetic element SCCmec typeIV (85%), which is commonly 
known to be associated with CA-MRSA infections (Wang et al. 2010; Smyth et al. 2011; 
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Valsesia et al. 2010). Similar results were also obtained in the study conducted by Tokajian 
et al. (2010) in Lebanon, where SCCmecIV was detected in 88% of MRSA isolates. The 
predominance of SCCmec typeIV in the community is probably due to its small size 
compared to other SCCmec elements which facilitates its transfer to MSSA strains 
(Robinson and Enright 2004; David and Daum 2010). Several studies have described that 
PVL along with SCCmec typesIV or V are markers for CA-MRSA infections in Europe 
and USA (Tristan et al. 2007; Vandenesch et al. 2003; Shukla et al. 2004), while in 
Australia the majority of CA-MRSA were found to be PVL negative (O’Brien et al. 2004). 
It is worth mentioning that all MRSA isolates, in our study, harboring SCCmecIV were 
PVL positive which agrees with previous results (Tokajian et al. 2010; Khalil et al. 2012; 
Diep et al. 2004; Deresinski 2005). On the other hand, all (n=5) MRSA isolates harboring 
SCCmecV were PVL negative, and this was in harmony with several other studies 
conducted in Lebanon and elsewhere (Tokajian et al. 2010; Khalil et al. 2012; Feng et al. 
2008; Adler et al. 2012; Chmelnitsky et al. 2007). One isolate in our study harbored 
SCCmecIII, which is known to be associated with HA-MRSA (Ma et al. 2002; Yamamoto 
et al. 2010; Wang et al. 2010), and this isolate was additionally multidrug resistant. 
Resistance against at least three drugs is associated with the presence of the junkyard 
region in SCCmec element typeIII within which are the genes that confer resistance to non-
β-lactam antibiotics (David and Daum 2010).  
Using default parameters of BURP, resultant spa types were grouped into 15 spa 
CCs and 25 singletons. Seventy one different spa types were detected in this study with 
53 different spa types belonging to the MSSA lineage compared to 25 in the MRSA 
lineage. This clearly shows the wide diversity of MSSA compared to MRSA that was 
also shown in the study conducted by Khalil et al. (2012) and Grundmann et al. (2010). 
The most prevalent spa type among MRSA was t044 (12.8%), which is also a common 
finding from isolates detected in the region (Jordan (10.7%) and Lebanon (37.7%) 
(Khalil et al. 2012; Tokajian et al. 2010) as well as in Europe (Grundmann et al. 2010; 
Deurenberg and Stobberingh 2008). On the other hand, the most prevalent spa type 
observed among the MSSA lineage was t021 (7.5%), which was not comparable with the 
findings of Khalil et al. (2012) and Tokajian et al. (2010), however, this isolate is 
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commonly found in Ireland (7.1%), Romania (12%), Portugal (4.2%) and other areas in 
Europe (Grundmann et al. 2010; Deurenberg and Stobberingh 2008). 
Thirty six isolates, within which 11 were MRSA and 25 were MSSA, representing 
all spa-CCs were MLST-typed. Twenty five allelic profiles were generated with the most 
prevalent STs being ST80 (11%) and ST30 (8%), which was in harmony with previous 
findings in Lebanon (Tokajian et al. 2010). These STs were also prevalent in Jordan 
(Khalil et al. 2012), Kuwait (Udo et al. 2008; Udo et al. 2010), and Israel (Adler et al. 
2010). Seven MRSA clones along with 20 MSSA clones were identified. Two out of the 5 
major international PVL positive CA-MRSA clones were detected in our study 
(European/Middle Eastern CC80:MRSA:IV and Southwest Pacific CC30:MRSA:IV 
clones). Additionally, 3 out of the 12 known HA-MRSA clones were also detected in the 
study (Brazilian/Hungarian CC8:MRSA:III, Pediatric CC5:MRSA:IV and UK EMRSA-15 
CC22:MRSA:IV clones) (Deurenberg and Stobberingh 2008). Majority of MSSA strains 
detected represent international pandemic clones belonging to CC1, CC5, CC8, CC121 and 
CC30 (Strommenger et al. 2006). Enright et al. (2002) has illustrated that the major MRSA 
lineages (CC5, CC22 and CC30) have emerged from epidemic MSSA lineages. 
PFGE analysis of 36 isolates revealed 32 different genotypes when 80% cutoff 
similarity was employed. This clearly showed the high genetic diversity of the collected S. 
aureus isolates. Several conducted studies have shown the higher diversity detected using 
PFGE compared to that defined by spa typing and/or MLST (Bosch et al. 2010; Cookoson 
et al. 2007). The need to introduce clustering analysis when conducting PFGE is of high 
importance to create databases that can be used for long-term epidemiological studies. 
Typing results using MLST and PFGE showed that several isolates belonging to 
the same MLST CCs were assigned to different PFGE clusters; CC30 and CC80 strains 
were present in more than one PFGE cluster. However, strains that belong to the same 
PFGE cluster generally belonged to the same MLST CC (e.g. CC15). This suggested that 
PFGE may have better discriminatory power than MLST for typing of S. aureus, which 
agreed with the findings of Xie et al. (2011) and Blanc et al. (2007). 
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Clustering SCCmec with MLST showed that the PVL positive ST80-MRSA-IV 
(6.9%) followed by PVL positive ST30-MSSA (5.3%) were the predominant types. The 
majority of the MRSA in the PVL positive ST80-MRSA-IV clone harbored spa type t044 
(3.8%) followed by t131 (2.3%) and t6476 (0.8%). The study done by Tokajian et al. 
(2010) has revealed that the majority of isolates (37.7%) belonged to ST80-MRSA-IVc 
and were spa t044. This was also in harmony with other conducted studies showing of 
ST80 clone in the region (Khalil et al. 2012; Udo et al. 2008; Udo et al. 2010; Adler et al. 
2010). This clone, known as the European clone (Goering et al. 2009; Deurenberg and 
Stobberingh 2008), has most probably disseminated from the Middle East. Goering et al. 
(2009) showed that the majority of 294 collected CC80:ST80:IV cases has family 
relationships in the Middle East. Since Denmark is a country with very low prevalence of 
MRSA, it is most likely that this clone was introduced into the Denmark from immigrants 
coming from the Middle East (Goering et al., 2009). This was also supported by the results 
obtained by Maier et al. (2007) who showed that travelers returning from Dead Sea area 
towards Germany as well as patients having family relationships from Turkey carried this 
clone. Finally, Francois et al. (2008) has shown that travelers returning from Tunisia and 
Libya towards Switzerland carried this clone too. Hence, studies that aim at defining the 
disease burden from this clone in Lebanon and the neighboring countries should be 
conducted to limit its future spread in the region as well as other areas (Tokajian et al. 
2012). Thus, intervention and prevention control measures that aim at systematic 
decolonization of MRSA carriers, antibiotic stewardship for containing resistance 
development and improvement of effective vaccine therapies is highly recommended for 
limiting the overall burden of predominant clones (Skov et al. 2012).  
It is noteworthy, that one isolate in our study collected from a three year old female 
was MSSA and PVL negative and typed as spa t044. This isolate is unique since it is 
usually known to be MRSA (Grundmann et al. 2010; Deurenberg and Stobberingh 2008; 
David and Daum 2010). The isolate had also distinct allelic profile from the known ST80 
(1-3-1-14-11-51-10), where its allelic profile was similar to ST97 (3-1-1-1-1-5-3) with a 
pulsotype that was different from its MRSA counterpart. 
 39 
 
PVL positive ST30-MRSA-IV was detected in our study in 1.5% of isolates which 
indicated that ST30-MSSA strains acquired the small mobile SCCmec typeIV element and 
disseminated consequently to become community-associated.PVL positive ST30-MSSA 
clone, commonly known as phage type 80/81, is one of the most remarkable bacterial 
clones that have caused epidemics in the 20
th
 century. This clone has emerged in the 1950s 
in the community as well as in hospital settings and was successfully eradicated after the 
introduction of methicillin into clinical practice (Deurenberg and Stobberingh 2008). 
However, this clone has reemerged and acquired SCCmec typeIV element and became the 
community acquired ST30-MRSA-IV clone. ST30-MSSA also acquired SCCmecII 
element into a single locus variant of ST30 and was introduced into hospital settings to 
become ST36-MRSA-II clone (UK EMRSA-16) commonly found in the United Kingdom 
(Enright et al. 2002; Deurenberg and Stobberingh 2008).  
In conclusion, this study provides a comprehensive overview of the molecular 
epidemiology and genetic diversity of S. aureus isolates collected from the largest 
university hospital in Lebanon. Application of multiple genotypic typing methods provided 
key information about the clonal relatedness of the isolates that increased our 
understanding of S. aureus clones circulating in Lebanon. The persistent spread of the PVL 
positive ST80-MRSA-IV clone in Lebanon as well as neighboring countries calls for novel 
approaches for infection control measures that would limit its spread. The wide diversity 
observed within MRSA and MSSA clones raises the question whether these clones will 
eventually replace the prevalent local clones or not. Hence, continuous surveillance studies 
with the aid of molecular typing techniques, continues to be of great importance for 
understanding the local epidemiology of S. aureus. Limitations of our study lied in the 
small number of isolates as well as lack of information about the clinical history of patients 
that would have given us insights to track clones disseminating between the hospitals and 
in the community. 
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CHAPTER SIX 
CONCLUSION 
 
 This study reflects the epidemiological characterization of S. aureus isolates 
collected from the biggest university hospital in Lebanon through employment of 
four genotypic techniques: SCCmec, spa, MLST and PFGE. 
 High genetic diversity was demonstrated by all of the typing methods. 
 SCCmec typing of MRSA showed the prevalence (49%) of SCCmec typeIV (d, e, f, 
g and h) followed by IVa (31%), V (13%), IVc (5%) and III (3%). 
 spa typing revealed 71 different spa types with the most common being t021, t044 
and t267. 
 53 different spa types were identified among MSSA isolates compared to 25 
among MRSA isolates. 
 Using BURP analysis, spa types were clustered into 40 different groups with 15 
groups having more than one spa type and 25 singletons. 
 9 novel spa types were identified: t9127, t9128, t9129, t9804, t9805, t9806, t9830, 
t9831 and t9832. 
 25 distinct allelic profiles were generated by MLST with ST80 (11%) and ST30 
(8%) being the predominant STs. 
 PFGE aimed at defining 32 PFGE clusters among 36 tested isolates by employing 
80% cutoff similarity. 
 PFGE has been shown to have better discriminatory power than MLST in typing of 
S. aureus. 
 Seven MRSA clones along with twenty MSSA clones were identified. 
 PVL positive ST80-MRSA-IV and ST30-MSSA clones were the major 
disseminating MRSA and MSSA clones respectively.  
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 Nineteen resistant profiles were obtained in this study. MRSA isolates were mainly 
resistant to augmentin, cephalothin and oxacillin, while MSSA to clindamycin and 
erythromycin.  
 Prevalence of SCCmec IV (85%) among MRSA isolates suggests that S. aureus 
infection among the Lebanese population is due to CA-MRSA. 
 Access to specific and precise typing methods that offer cost effective intervention 
and prevention strategies is of high importance for continuous surveillance and 
outbreak investigations of pandemic clones. 
 Persistence of ST80-MRSA-IV clone calls for further infection control measures 
that aids in limiting its regional as well as global spread. 
 Employment of larger scale studies that includes large number of local samples as 
well as patient clinical history is indispensable for understanding the genetic 
relationships as well as evolution of circulating S. aureus in Lebanon. 
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ANNEX 
 
Sample # Specimen PVL Methicillin SCCmec 
Subtype 
spa type spa-CC ST 
Type 
MLST 
CC 
Antibiotic Resistance 
HST 001 Sputum Neg. Susceptible  t008 304/121    
HST 002 Blood Neg. Susceptible  t9128 Singletons    
HST 003 Pus Neg. Susceptible  t9127 084    
HST 004 Wound Neg. Susceptible  t084 Singletons    
HST 005 Nose Neg. Susceptible  t521 267    
HST 006 Joint Fluid Neg. Susceptible  t4458 No founder    
HST 007 Wound Pos. Resistant IV t9135 044   AUG, KF, OXA 
HST 008 Pus Neg. Susceptible  t571 Singletons   CLI, ERY 
HST 009 Wound Pos. Resistant IVc t019 021 30 30 AUG, KF, OXA 
HST 010 Others Neg. Susceptible  t084 084    
HST 011 Sputum Neg. Resistant IV t032 032   AUG, KF, CIP, CLI, ERY, OXA 
HST 012 Pus Neg. Susceptible  t279 084    
HST 013 Others Neg. Susceptible  t521 267    
HST 014 Others Neg. Susceptible  t279 084    
HST 015 Toe Neg. Susceptible  t304 304/121    
HST 016 Wound Neg. Susceptible  t095 Singletons    
HST 017 Eye Pos. Resistant IV t131 044   AUG, KF, OXA, TET 
HST 018 Eye Pos. Resistant IV t131 044   AUG, KF, OXA, TET 
HST 019 Pus Neg. Susceptible  t701 304/121    
HST 020 Tracheal Aspirate Neg. Susceptible  t2177 186/786/690   ERY 
HST 021 Tracheal Aspirate Neg. Susceptible  t9210 084 199 15  
HST 022 Sputum Neg. Susceptible  t088 306/002    
HST 023 Sputum Neg. Susceptible  t9129 267 97 97 CLI, ERY, TET 
HST 024 Others Neg. Susceptible  t937 No founder 291 398  
HST 025 Pus Neg. Susceptible  t304 304/121    
HST 026 Eye Neg. Susceptible  t304 304/121    
HST 027 Sputum Neg. Susceptible  t002 306/002    
List of all the spa types found among our isolates, along with their respective spa clonal complexes (spa-CCs), 
SCCmec subtypes, ST types, MLST CCs and antibiotic resistance pattern. 
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HST 028 Abdominal Pos. Resistant IV t002 306/002   AUG, KF, CLI, ERY, OXA, 
TET 
HST 029 Urine Neg. Susceptible  t045 306/002   CLI, ERY 
HST 030 Wound Neg. Resistant IVa t786 186/786/690   AUG, KF, OXA 
HST 031 Pus Neg. Susceptible  t091 No founder   TET 
HST 032 Others Neg. Resistant IVa t214 306/002   AUG, KF, OXA 
HST 033 Eye Neg. Resistant IV t1214 032   AUG, KF, CIP, CLI, ERY, OXA 
HST 034 Pus Pos. Resistant IVa t121 304/121   AUG, KF, CIP, ERY, OXA 
HST 035 Pus Neg. Resistant IVa t186 186/786/690   AUG, KF, ERY, OXA 
HST 036 Sputum Neg. Susceptible  t088 306/002    
HST 037 Others Neg. Susceptible  t1149 No founder    
HST 038 Others Neg. Resistant IVa t214 306/002 5 5 AUG, KF, OXA 
HST 039 Tracheal Aspirate Neg. Resistant IVa t386 Excluded   AUG, KF, CLI, ERY, OXA, 
TET 
HST 040 Nose Neg. Resistant IV t3468 No founder 72 72  
HST 041 Tracheal Aspirate Neg. Resistant IVa t002 306/002 5 5 AUG, KF, OXA 
HST 042 Eye Neg. Susceptible  t091 No founder    
HST 043 Tracheal Aspirate Neg. Susceptible  t2096 No founder 34 30  
HST 044 Tracheal Aspirate Pos. Resistant IVc t1752 021   AUG, KF, OXA 
HST 045 Others Neg. Susceptible  t1149 No founder    
HST 046 Wound Neg. Susceptible  t1149 No founder    
HST 047 Others Pos. Resistant IV t380 Excluded   AUG, KF, OXA, TET 
HST 048 Pus Neg. Susceptible  t1492 084   TET 
HST 049 Pus Pos. Resistant IV t358 No founder    
HST 050 Tracheal Aspirate Neg. Susceptible  t132 Excluded    
HST 051 Sputum Neg. Susceptible  t9806 No founder 789 789 CIP, TET 
HST 052 Wound Pos. Resistant IV t122 021   AUG, KF, OXA 
HST 053 Wound Pos. Susceptible  t9803 084    
HST 054 Throat Neg. Susceptible  t091 No founder    
HST 055 Nose Neg. Susceptible  t9804 Singletons    
HST 056 Others Neg. Susceptible  t267 267    
HST 057 Others Pos. Resistant IVa t306 306/002   AUG, KF, OXA 
HST 058 Wound Neg. Susceptible  t021 021    
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HST 059 Pus Pos. Susceptible  t9805 Singletons    
HST 060 Sputum Neg. Resistant IVa t9832 Singletons 22 22 AMP, AUG, KF, OXA 
HST 061 Tracheal Aspirate Neg. Resistant V t267 267   AMP, AUG, KF, OXA, TET 
HST 062 Pus Neg. Susceptible  t021 021    
HST 063 Catheter Neg. Susceptible  t021 021    
HST 064 Pus Neg. Susceptible  t005 032    
HST 065 Pus Pos. Susceptible  t127 Singletons   TET, SXT 
HST 066 Tracheal Aspirate Neg. Resistant V t267 267   TET 
HST 067 Tracheal Aspirate Neg. Susceptible  t127 Singletons 1 1  
HST 068 Pus Pos. Susceptible  t127 Singletons   CLI, ERY 
HST 069 Sputum Neg. Susceptible  t315 306/002 361 361 CIP, ERY 
HST 070 Wound Neg. Susceptible  t004 Singletons    
HST 071 Wound Neg. Susceptible  t004 Singletons    
HST 072 Pus Pos. Susceptible  t355 Singletons    
HST 073 Others Neg. Susceptible  t078 No founder 25 25  
HST 074 Others Pos. Susceptible  t3184 Singletons   CLI, ERY 
HST 075 Eye Neg. Susceptible  t304 304/121 6 6  
HST 076 Tracheal Aspirate Neg. Resistant V t267 267   AUG, KF, OXA 
HST 077 Sputum Neg. Resistant III t037 021 239 239 AUG, KF, CIP, CLI, ERY, 
OXA, TET, SXT 
HST 078 Pus Pos. Resistant IV t6476 Singletons 80 80 AUG, KF, OXA 
HST 079 Abscess Pos. Resistant IV t019 021   AUG, KF, OXA 
HST 080 Tracheal Aspirate Neg. Susceptible  t132 Excluded 46 45  
HST 081 Tracheal Aspirate Neg. Susceptible  t774 084 15 15  
HST 082 Abscess Pos. Susceptible  t127 Singletons   CLI, ERY 
HST 083 Wound Pos. Susceptible  t021 021    
HST 084 Abdominal Neg. Resistant V t9831 No founder 72 72 AUG, KF, OXA 
HST 085 Wound Neg. Resistant V t9831 No founder   AUG, KF, OXA 
HST 086 Blood  Neg. Susceptible  t127 Singletons    
HST 087 Drainage Pos. Susceptible  t355 Singletons    
HST 088 Tracheal Aspirate Neg. Susceptible  t861 Singletons 508 45  
HST 089 Nose Neg. Susceptible  t091 No founder 7 7  
HST 090 Pus Neg. Susceptible  t349 No founder 1995 25  
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HST 091 Bronchial Lavage Pos. Resistant IV t044 044 80 80 AUG, KF, OXA 
HST 092 Tracheal Aspirate Neg. Susceptible  t002 306/002   CLI, ERY 
HST 093 Pleural Tap Neg. Susceptible  t159 No founder    
HST 094 Pus Neg. Susceptible  t306 306/002   TET 
HST 095 Others Neg. Susceptible  t166 No founder 34 30 TET 
HST 096 Pus Pos. Susceptible  t021 021 30 30  
HST 097 Wound Neg. Susceptible  t084 084    
HST 098 Pus Neg. Susceptible  t1149 No founder 291 398  
HST 099 Others Neg. Susceptible  t6702 Singletons    
HST 100 Abdominal Fluid Pos. Resistant IV t044 044   AUG, KF, OXA 
HST 101 Pus Neg. Susceptible  t1149 No founder    
HST 102 Tracheal Aspirate Neg. Susceptible  t267 267    
HST 103 Pus Neg. Susceptible  t315 306/002   CIP 
HST 104 Pus Pos. Resistant IVa t690 186/786/690   KF, OXA, TET 
HST 105 Pus Pos. Resistant IVa t690 186/786/690   AUG, KF, OXA, TET 
HST 106 Ear Neg. Susceptible  t9830 Singletons    
HST 107 Others Pos. Resistant IV t044 044   AUG, KF, OXA, TET 
HST 108 Others Neg. Susceptible  t166 No founder    
HST 109 Nose Neg. Susceptible  t091 No founder    
HST 110 Tracheal Aspirate Neg. Susceptible  t186 186/786/690 88 88  
HST 111 Sputum Neg. Susceptible  t377 Singletons 770 770  
HST 112 Fluid Neg. Susceptible  t012 021 30 30  
HST 113 Pus Neg. Susceptible  t4793 304/121    
HST 114 Sputum Neg. Susceptible  t377 Singletons    
HST 115 Others Neg. Susceptible  t659 No founder 720 121 CLI, ERY 
HST 116 Pus Neg. Susceptible  t044 044 97 97  
HST 117 Pus Pos. Resistant IV t044 044   AUG, KF, OXA, TET 
HST 118 Sputum Neg. Susceptible  t9841 Singletons    
HST 119 Abscess Pos. Resistant IV t131 044 80 80 AUG, KF, OXA 
HST 120 Tracheal Aspirate Neg. Susceptible  t084 084 199 15 TET 
HST 121 Pus Pos. Susceptible  t008 304/121 8 8 CIP 
HST 122 Others Neg. Susceptible  t3468 No founder    
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HST 123 Sputum Neg. Susceptible  t2467 304/121    
HST 124 Catheter Neg. Susceptible  t3468 No founder    
HST 125 Skin Neg. Susceptible  t021 021    
HST 126 Bronchial Lavage Neg. Susceptible  t9805 Singletons    
HST 127 Pus Neg. Resistant IV t9832 Singletons   AUG, KF, CIP, CLI, ERY, OXA 
HST 128 Abscess Pos. Resistant IV t044 044   AUG, KF, OXA 
HST 129 Tracheal Aspirate Neg. Susceptible  t267 267    
HST 130 Tracheal Aspirate Neg. Resistant IV t021 021 80 80 AIG, KF, OXA 
HST 131 Sputum Neg. Susceptible  t021 021    
HST 132 Sputum Neg. Susceptible  t005 032 641 641  
